Central Nervous System Carcinoma clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor
Sorry, in progress, not accepting new patients
This phase III trial compares memantine to placebo in treating patients with primary central nervous system tumors. Memantine may block receptors (parts of nerve cells) in the brain known to contribute to a decline in cognitive function. Giving memantine may make a difference in cognitive function (attention, memory, or other thought processes) in children and adolescents receiving brain radiation therapy to treat a primary central nervous system tumors.
Oakland, California and other locations
Last updated: